What is the Catalyst Edge convergence score for DRMA?

As of 2026-09-28, DRMA has a convergence score of — with conviction tier — and 0 independent signals firing. Score is a weighted aggregate across SEC filings, insider activity, options flow, dark-pool prints, short-squeeze metrics, and macro regime.

How is DRMA's score calculated?

Each signal contributes weighted points; weights are auto-tuned weekly against published outcome history. Full methodology + audit at https://catalystedgescanner.com/methodology/ and https://catalystedgescanner.com/trust/.

How accurate has Catalyst Edge been on DRMA?

On the last 10 published picks featuring DRMA, 4 hit the +2% intraday threshold (40% hit rate). Outcomes audited daily.

Catalyst Edge · Scanner · Tickers · DRMA

CATALYST DOSSIER · UPDATED 2026-09-28

$DRMA

Unclassified · convergence — · conviction —

Convergence Score

—

Conviction

—

Signals Firing

Track Record

4/10

Quick tools:🃏 Swipe deck 🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $DRMA?

DRMA -17 AVOID biotech

Quantitative

Convergence score: -17 (4 signals firing YoY)

Catalysts

Multi-spoke convergence: 4 convergent signals fired: regsho, auto_regsho_threshold, auto_macro_mta_ridership, auto_macro_vix_term

Risks

Hard-to-borrow / FTD risk: Borrow rate 6.0%, distress score 30
Reg SHO threshold list: On NASDAQ threshold list (2026-08-24)

Bear case

Multiple compression: If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis

Sympathy basket (cerebro)

BWA via consumer r=+0.83 sympathetic (score 1)
LOT via consumer r=+0.83 sympathetic (score -1)
OPTU via comms r=+0.67 sympathetic (score -14)
TBCH via comms r=+0.67 sympathetic (score -15)
STDN via materials r=+0.55 sympathetic (score -2)
USAR via materials r=+0.55 sympathetic (score -13)

Signals Firing

No active signals this cycle.

Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Pick Track Record

Date	List	Next-day max run	Next-day close	Hit +2%?
2026-08-27	sec_top_gappers	+8.2%	-8.2%	✓ hit
2026-08-27	sec_top_moat_emerging	+8.2%	-8.2%	✓ hit
2026-08-19	sec_top_gappers	+1.4%	-6.1%	—
2026-08-19	sec_top_moat_emerging	+1.4%	-6.1%	—
2026-08-18	sec_top_gappers	+10.5%	+2.8%	✓ hit
2026-08-18	sec_top_moat_emerging	+10.5%	+2.8%	✓ hit
2026-08-17	sec_top_gappers	+0.7%	-2.1%	—
2026-08-17	sec_top_moat_emerging	+0.7%	-2.1%	—
2026-08-05	sec_top_gappers	+0.9%	-5.1%	—
2026-08-05	sec_top_moat_emerging	+0.9%	-5.1%	—

Lifetime: 4/10 wins · hit-rate 40.0% on +2% intraday

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for DRMA. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Tier 1 setups touched +2% intraday 48.1% of the time across 343 tracked calls. Baseline for everything else: 40.2%. That is a +7.9 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/

Click Become a Founding Member below.
Pay $99 once — not monthly, not ever again.
You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.

29 of 30 founding seats left. The price goes up when they are gone.

Become a Founding Member — $99 once

One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →